The FDA approved Roche’s monoclonal antibody to treat COVID-19 Dec. 21, about three weeks after the agency reversed its authorization for Eli Lilly’s monoclonal drug.
Charlottesville-based University of Virginia Health System researchers found commonly used antidepressants known as selective serotonin reuptake inhibitors can interact with inflammation in a mother’s body, resulting in permanent brain changes in a fet…
Early evidence suggests a cocktail of two existing medications could mitigate or eliminate brain fog among patients with long COVID-19, according to researchers at Yale University in New Haven, Conn.
Osbert Blow, MD, PhD, the CEO of Corpus Christi, Texas-based Christus Spohn Health System, will retire on Dec. 30, according to the Corpus Christi Caller Times.